chr6-87514311-C-CA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_020320.5(RARS2):c.*101_*102insT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 566,554 control chromosomes in the GnomAD database, including 464 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.095 ( 442 hom., cov: 0)
Exomes 𝑓: 0.13 ( 22 hom. )
Consequence
RARS2
NM_020320.5 3_prime_UTR
NM_020320.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.613
Genes affected
RARS2 (HGNC:21406): (arginyl-tRNA synthetase 2, mitochondrial) This nuclear gene encodes a protein that localizes to the mitochondria, where it catalyzes the transfer of L-arginine to its cognate tRNA, an important step in translation of mitochondrially-encoded proteins. Defects in this gene are a cause of pontocerebellar hypoplasia type 6 (PCH6). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 6-87514311-C-CA is Benign according to our data. Variant chr6-87514311-C-CA is described in ClinVar as [Benign]. Clinvar id is 1221069.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RARS2 | NM_020320.5 | c.*101_*102insT | 3_prime_UTR_variant | 20/20 | ENST00000369536.10 | NP_064716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RARS2 | ENST00000369536.10 | c.*101_*102insT | 3_prime_UTR_variant | 20/20 | 1 | NM_020320.5 | ENSP00000358549 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0952 AC: 10671AN: 112042Hom.: 439 Cov.: 0
GnomAD3 genomes
AF:
AC:
10671
AN:
112042
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.130 AC: 58892AN: 454480Hom.: 22 AF XY: 0.129 AC XY: 31590AN XY: 244210
GnomAD4 exome
AF:
AC:
58892
AN:
454480
Hom.:
AF XY:
AC XY:
31590
AN XY:
244210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0953 AC: 10679AN: 112074Hom.: 442 Cov.: 0 AF XY: 0.0953 AC XY: 5088AN XY: 53382
GnomAD4 genome
AF:
AC:
10679
AN:
112074
Hom.:
Cov.:
0
AF XY:
AC XY:
5088
AN XY:
53382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
RARS2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 28, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 21, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at